Jill Olydam

7PUBLICATIONS
5CO-AUTHORS
Environmental epidemiologyCharacterisation of biological macromoleculesAllergyMolecular targetsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 12, 2026
Serum Eosinophil-Derived Neurotoxin (EDN) as a Biomarker for Treatment Response in Atopic Dermatitis.

|Apr 20, 2026
Serum proteomic changes in atopic dermatitis patients treated with cyclosporine.

|Oct 21, 2023
Upadacitinib treatment in a real-world difficult-to-treat atopic dermatitis patient cohort.

Anne R Schlösser, Neill Boeijink, Jill Olydam

|Jul 21, 2023
Real-world effectiveness of abrocitinib treatment in patients with difficult-to-treat atopic dermatitis.

J I Olydam, A R Schlösser, P Custurone

|May 11, 2023
Prediction of response to dupilumab treatment.

DirkJan Hijnen, Jill Olydam

|Jan 26, 2023
Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice.

Anne R Schlösser, Madena Shareef, Jill Olydam

Pageof 2

Frequent Collaborators

5 joint publications

DirkJan Hijnen

4 joint publications

Tamar E C Nijsten

3 joint publications

Anne R Schlösser

1 joint publications

L E M de Wijs